Bristol could seek FDA’s OK on 3 cancer drugs
- Share via
From the Associated Press
Bristol-Myers Squibb Co. said it would submit at least one new cancer drug for approval next year and might file a total of three with the Food and Drug Administration.
The company plans to file a marketing application on Ixabepilone for breast cancer next year. It will file applications on Ipilimumab for melanoma and Vinflunine for bladder cancer in late 2007 or 2008.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
